Preparation method of 1-(3-methoxyphenyl)ethylamine_Kain Industrial Additive

Background and overview[1] Rivastigmine is an acetylcholinesterase inhibitor with the trade name Exelon, produced by Novartis Pharmaceuticals Company of the United States. The FDA approved the oral liquid and capsules of this product for the treatment of Alzheimer’s disease on April 21, 2000. The drug has been approved for sale in 70 countries including EU…